Suchergebnisse - "Libertin, Claudia R"

PubPharm (64)

1

Decoding Immuno-Competence : A Novel Analysis of Complete Blood Cell Count Data in COVID-19 Outcomes

enthalten in: Biomedicines | 2024

von Kempaiah, P. | Libertin, C. | Chitale, R. | +7

2

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy : results from the randomised phase 3 'LIVE-AIR' trial

enthalten in: Thorax | 2023

von Temesgen, Z. | Kelley, C. | Cerasoli, F. | +110

3

Data structuring may prevent ambiguity and improve personalized medical prognosis

enthalten in: Molecular aspects of medicine | 2023

von Libertin, C. | Kempaiah, P. | Gupta, Y. | +5

4

Disseminated mycobacterial infections after tumor necrosis factor inhibitor use, revealing inborn errors of immunity

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Squire, J. | Libertin, C. | Powers, H. | +6

5

From numbers to medical knowledge : harnessing combinatorial data patterns to predict COVID-19 resource needs and distinguish patient subsets

enthalten in: Frontiers in medicine | 2023

von Satashia, P. | Franco, P. | Rivas, A. | +15

6

A retrospective analysis of normal saline and lactated ringers as resuscitation fluid in sepsis

enthalten in: Frontiers in medicine | 2023

von Isha, S. | Satashia, P. | Yarrarapu, S. | +23

7

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia

enthalten in: bioRxiv.org | 2022

von Temesgen, Z. | Assi, M. | Vergidis, P. | +17

8

Low antispike antibody levels correlate with poor outcomes in COVID-19 breakthrough hospitalizations

enthalten in: Journal of internal medicine | 2022

von Sanghavi, D. | Bhakta, S. | Wadei, H. | +15

9

Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Bhakta, S. | Sanghavi, D. | Johnson, P. | +14

10

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR) : a phase 3, randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Temesgen, Z. | Burger, C. | Baker, J. | +113

CommentIn: Lancet Respir Med. 2022 Mar;10(3):223-224. - PMID 34863335

1
2
3
4
5
6
7
Nächster »
[7]